First 'pharmacovigilance' center launched in India
Healthcare IT News
By Molly Merrill, Contributing Writer
NEW YORK – Accenture and the Bristol-Myers Squibb Company have joined forces to launch the pharmaceutical industry’s first pharmacovigilance center, in Chennai, India, to monitor safety data collected on medicines. Pharmacovigilance entails the capture, assessment and reporting of potential side effects on medicines.